291 related articles for article (PubMed ID: 30715413)
1. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
Crank MC; Mascola JR; Graham BS
J Infect Dis; 2019 Apr; 219(Suppl_1):S107-S109. PubMed ID: 30715413
[No Abstract] [Full Text] [Related]
2. How Live Attenuated Vaccines Can Inform the Development of Broadly Cross-Protective Influenza Vaccines.
Rudraraju R; Mordant F; Subbarao K
J Infect Dis; 2019 Apr; 219(Suppl_1):S81-S87. PubMed ID: 30715386
[No Abstract] [Full Text] [Related]
3. Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.
Eichelberger MC; Monto AS
J Infect Dis; 2019 Apr; 219(Suppl_1):S75-S80. PubMed ID: 30715357
[TBL] [Abstract][Full Text] [Related]
4. Influenza Vaccines: Good, but We Can Do Better.
Paules CI; Fauci AS
J Infect Dis; 2019 Apr; 219(Suppl_1):S1-S4. PubMed ID: 30715469
[No Abstract] [Full Text] [Related]
5. Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic.
Morens DM; Taubenberger JK
J Infect Dis; 2019 Apr; 219(Suppl_1):S5-S13. PubMed ID: 30715352
[TBL] [Abstract][Full Text] [Related]
6. Development of live attenuated influenza vaccines against pandemic influenza strains.
Coelingh KL; Luke CJ; Jin H; Talaat KR
Expert Rev Vaccines; 2014 Jul; 13(7):855-71. PubMed ID: 24867587
[TBL] [Abstract][Full Text] [Related]
7. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2015 Oct; 90(42):561-71. PubMed ID: 26477059
[No Abstract] [Full Text] [Related]
8. Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin Proteins.
Ross TM
J Infect Dis; 2019 Apr; 219(Suppl_1):S57-S61. PubMed ID: 30715379
[TBL] [Abstract][Full Text] [Related]
9. Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain.
Krammer F; Palese P
J Infect Dis; 2019 Apr; 219(Suppl_1):S62-S67. PubMed ID: 30715353
[TBL] [Abstract][Full Text] [Related]
10. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
[No Abstract] [Full Text] [Related]
11. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
[No Abstract] [Full Text] [Related]
12. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
Morgan SB; Hemmink JD; Porter E; Harley R; Shelton H; Aramouni M; Everett HE; Brookes SM; Bailey M; Townsend AM; Charleston B; Tchilian E
J Immunol; 2016 Jun; 196(12):5014-23. PubMed ID: 27183611
[TBL] [Abstract][Full Text] [Related]
13. Epitope specific T-cell responses against influenza A in a healthy population.
Savic M; Dembinski JL; Kim Y; Tunheim G; Cox RJ; Oftung F; Peters B; Mjaaland S
Immunology; 2016 Feb; 147(2):165-77. PubMed ID: 26489873
[TBL] [Abstract][Full Text] [Related]
14. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
[No Abstract] [Full Text] [Related]
15. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
[No Abstract] [Full Text] [Related]
16. The Role of Matrix Protein 2 Ectodomain in the Development of Universal Influenza Vaccines.
Saelens X
J Infect Dis; 2019 Apr; 219(Suppl_1):S68-S74. PubMed ID: 30715367
[TBL] [Abstract][Full Text] [Related]
17. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
[No Abstract] [Full Text] [Related]
18. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2017 Mar; 92(12):129-44. PubMed ID: 28337863
[No Abstract] [Full Text] [Related]
19. Universal influenza vaccines: a realistic option?
de Vries RD; Altenburg AF; Rimmelzwaan GF
Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S120-S124. PubMed ID: 27130671
[TBL] [Abstract][Full Text] [Related]
20. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
Blanco-Lobo P; Nogales A; RodrÃguez L; MartÃnez-Sobrido L
Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]